Literature DB >> 2171051

DNA analysis by flow cytometry in nonsmall cell lung cancer: relationship to epidermal growth factor receptor, histology, tumour stage and survival.

H Dazzi1, N Thatcher, P S Hasleton, R Swindell.   

Abstract

In a retrospective study, surgical specimens of 136 patients with nonsmall cell lung cancer, were investigated for DNA content by flow cytometry. Seventy per cent of all tumours were aneuploid. Aneuploidy was a statistically significant factor for shorter survival and was independent of tumour size, histology, grade of differentiation, regional lymph node involvement, age and sex (P less than 0.02). A high proliferation index (greater than 7.5%) was also a prognostically unfavourable factor and was observed significantly more often in tumours where the majority of cells expressed epidermal growth factor receptor.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2171051     DOI: 10.1016/s0954-6111(08)80038-8

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  4 in total

1.  Near-diploid transitional cell carcinoma: a preliminary report.

Authors:  N H Chow; T S Tzai; S N Lin; W C Su; H L Cheng
Journal:  Int Urol Nephrol       Date:  1994       Impact factor: 2.370

2.  Aneuploidy and prognosis of non-small-cell lung cancer: a meta-analysis of published data.

Authors:  D Choma; J P Daurès; X Quantin; J L Pujol
Journal:  Br J Cancer       Date:  2001-07-06       Impact factor: 7.640

3.  The relationship of quantitative epidermal growth factor receptor expression in non-small cell lung cancer to long term survival.

Authors:  D Veale; N Kerr; G J Gibson; P J Kelly; A L Harris
Journal:  Br J Cancer       Date:  1993-07       Impact factor: 7.640

4.  Hypodiploidy, Ki-67 growth fraction and prognosis of surgically resected lung cancers.

Authors:  J L Pujol; J Simony; G Jolimoy; D Jaffuel; P Demoly; X Quantin; C Marty-Ané; J M Boher; R Charpentier; F B Michel
Journal:  Br J Cancer       Date:  1996-09       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.